1 |
SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1):12-49. doi:10.3322/caac.21820
doi: 10.3322/caac.21820
|
2 |
STOFFEL E M, BRAND R E, GOGGINS M. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention[J]. Gastroenterology, 2023, 164(5):752-765. doi:10.1053/j.gastro.2023.02.012
doi: 10.1053/j.gastro.2023.02.012
|
3 |
GUADAGNO N A, PROGIDA C. Rab GTPases: Switching to Human Diseases[J]. Cells, 2019, 8(8):909. doi:10.3390/cells8080909
doi: 10.3390/cells8080909
|
4 |
PARK J I, SONG K H, KANG S M,et al. BHMPS Inhibits Breast Cancer Migration and Invasion by Disrupting Rab27a-Mediated EGFR and Fibronectin Secretion[J]. Cancers (Basel),2022, 14(2):373. doi:10.3390/cancers14020373
doi: 10.3390/cancers14020373
|
5 |
CULINE S, HONORE N, CLOSSON V, et al. A small GTP-binding protein is frequently overexpressed in peripheral blood mononuclear cells from patients with solid tumours[J]. Eur J Cancer, 1994, 30(5): 670-674. doi:10.1016/0959-8049(94)90542-8
doi: 10.1016/0959-8049(94)90542-8
|
6 |
ZHEN Y, STENMARK H. Cellular functions of Rab GTPases at a glance[J]. J Cell Sci, 2015, 128(17):3171-3176.
|
7 |
CHEN X, LIAO X, ZHENG B, et al. Differential Plasma Proteins Identified via iTRAQ‐Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adenocarcinoma[J]. Dis Markers, 2023, 2023(1): 5145152. doi:10.1155/2023/5145152
doi: 10.1155/2023/5145152
|
8 |
MALESCI A, TOMMASINI M A, BONATO C, et al. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis[J]. Gastroenterology, 1987, 92(1):60-67. doi:10.1016/0016-5085(87)90840-7
doi: 10.1016/0016-5085(87)90840-7
|
9 |
LUO G, JIN K, DENG S, et al. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter[J]. Biochim Biophys Acta Rev Cancer, 2021, 1875(2):188409. doi:10.1016/j.bbcan.2020.188409
doi: 10.1016/j.bbcan.2020.188409
|
10 |
BALLEHANINNA U K, CHAMBERLAIN R S. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal[J]. J Gastrointest Oncol, 2012, 3(2):105-119. doi:10.1007/s13193-011-0042-1
doi: 10.1007/s13193-011-0042-1
|
11 |
HOMMA Y, HIRAGI S, FUKUDA M. Rab family of small GTPases: An updated view on their regulation and functions[J]. FEBS J, 2021, 288(1):36-55. doi:10.1111/febs.15453
doi: 10.1111/febs.15453
|
12 |
XU S, CAO B, XUAN G, et al. Function and regulation of Rab GTPases in cancers[J]. Cell Biol Toxicol, 2024, 40(1):28. doi:10.1007/s10565-024-09866-5
doi: 10.1007/s10565-024-09866-5
|
13 |
TANG Q, LENTO A, SUZUKI K, et al. Rab11-FIP1 mediates epithelial-mesenchymal transition and invasion in esophageal cancer[J]. EMBO Rep, 2021, 22(2):e48351. doi:10.15252/embr.201948351
doi: 10.15252/embr.201948351
|
14 |
KAJIHO H, KAJIHO Y, SCITA G. Harnessing membrane trafficking to promote cancer spreading and invasion: The case of RAB2A[J]. Small GTPases, 2018, 9(4):304-309. doi:10.1080/21541248.2016.1223990
doi: 10.1080/21541248.2016.1223990
|
15 |
WANG J, LUO X, LU J, et al. Rab22a promotes the proliferation, migration, and invasion of lung adenocarcinoma via up-regulating PI3K/Akt/mTOR signaling pathway[J]. Exp Cell Res, 2022, 416(2):113179. doi:10.1016/j.yexcr.2022.113179
doi: 10.1016/j.yexcr.2022.113179
|
16 |
JIANG C, LIU Z, YUAN J, et al. Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma[J]. Int J Mol Sci, 2023, 24(5):4335. doi:10.3390/ijms24054335
doi: 10.3390/ijms24054335
|
17 |
JIN J, WU Y, ZHOU D, et al. miR-448 targets Rab2B and is pivotal in the suppression of pancreatic cancer[J]. Oncol Rep, 2018, 40(3):1379-1389.
|
18 |
HU Y, LI Y, HUANG Y, et al. METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B[J]. Eur J Pharmacol, 2020, 879:173134. doi:10.1016/j.ejphar.2020.173134
doi: 10.1016/j.ejphar.2020.173134
|
19 |
TIAN Y, LUO Y, WANG J. MicroRNA-425 induces apoptosis and suppresses migration and invasion of human cervical cancer cells by targeting RAB2B[J]. Int J Immunopathol Pharmacol, 2021, 35:20587384211016131. doi:10.1177/20587384211016131
doi: 10.1177/20587384211016131
|
20 |
PANKOV R, YAMADA K M. Fibronectin at a glance[J]. J Cell Sci, 2002, 115(20):3861-3863. doi:10.1242/jcs.00059
doi: 10.1242/jcs.00059
|
21 |
ANSARI D, FRIESS H, BAUDEN M,et al.Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment[J].Oncotarget, 2018, 9(5):6644-6651. doi:10.18632/oncotarget.24019
doi: 10.18632/oncotarget.24019
|
22 |
ATTIEH Y, CLARK A G, GRASS C, et al. Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly[J].J Cell Biol, 2017, 216(11):3509-3520. doi:10.1083/jcb.201702033
doi: 10.1083/jcb.201702033
|
23 |
LIN Y, LI Y, CHEN X, et al. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway[J]. Biol Direct, 2024, 19(1):42. doi:10.1186/s13062-024-00481-2
doi: 10.1186/s13062-024-00481-2
|
24 |
YU S, YU X, SUN L, et al. GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway[J]. Oncogene, 2020, 39(27):5042-5055. doi:10.1038/s41388-020-1348-7
doi: 10.1038/s41388-020-1348-7
|
25 |
BAO H, HUO Q, YUAN Q, et al. Fibronectin 1: A Potential Biomarker for Ovarian Cancer[J].Dis Markers, 2021, 2021(6):1-11. doi:10.1155/2021/5561651
doi: 10.1155/2021/5561651
|
26 |
ZHANG X, LUO Y, CEN Y, et al. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1[J]. Cell Death Dis, 2022, 13(11):923. doi:10.1038/s41419-022-05285-8
doi: 10.1038/s41419-022-05285-8
|
27 |
GAMBHIR S, VYAS D, HOLLIS M, et al. Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies[J]. World J Gastroenterol, 2015, 21(11):3174-83. doi:10.3748/wjg.v21.i11.3174
doi: 10.3748/wjg.v21.i11.3174
|
28 |
CHEN X B, LI H Z, WEI X Y, et al. SERPINA1 promotes the invasion, metastasis, and proliferation of pancreatic ductal adenocarcinoma via the PI3K/Akt/NF-κB pathway[J]. Biochem Pharmacol, 2024, 230(2):116580. doi:10.1016/j.bcp.2024.116580
doi: 10.1016/j.bcp.2024.116580
|
29 |
ZUO X, ZHAO X, ZHANG X, et al. PTPN20 promotes metastasis through activating NF-κB signaling in triple-negative breast cancer[J].Breast Cancer Res, 2024, 26(1):1-16. doi:10.1186/s13058-024-01910-w
doi: 10.1186/s13058-024-01910-w
|
30 |
SUN W, QIN Y, WANG Z,et al. The NEAT1_2/miR-491 Axis Modulates Papillary Thyroid Cancer Invasion and Metastasis Through TGM2/NFκb/FN1 Signaling[J]. Front Oncol, 2021, 11:610547. doi:10.3389/fonc.2021.610547
doi: 10.3389/fonc.2021.610547
|